China has applied provisional import tariff rates lower than the most-favored-nation rates on 935 items starting from January 1, 2026, the Customs Tariff Commission of the China State Council announced on December 26, 2025.
“China will, for example, reduce tariffs on certain key components and advanced materials to support high-level technological development, on certain resources to facilitate green development, and on some medical products, including artificial blood vessels, to improve people’s well-being”, the commission said.
Full List
The tariff change has impacted 24 medical devices and 4 IVDs. Among them, the tariff rates of three products have been lowered to 0:
- Artificial joints
- Diagnostic or laboratory reagents on a backing for malaria
- Prepared diagnostic kits for Hepatitis A virus, Hepatitis B virus, Hepatitis C virus, Human Immunodeficiency Virus, and Treponema pallidum
Below is the full list. For tariff rates of specific products, please email info@ChinaMedDevice.com
Medical Devices
- Appliances specifically identifiable for ostomy use
- Nickel-titanium alloy wires for surgical implants
- Cobalt-chromium-molybdenum alloy rods for surgical implants
- Cobalt-chromium alloy tubes for vascular stents
- Titanium alloy bars, rods, profiles, and sections for surgical implants
- Electric breast pumps
- Angular contact ball bearings for medical equipment
- Contact lenses
- Detachable embolization coils for medical use
- Intracranial thrombectomy stents
- Umbrella-type inferior vena cava filters
- Dentures
- Dental fixatives
- Artificial joints
- Artificial blood vessels
- Artificial heart valves
- Hearing aids
- High-voltage solid-state modulator systems and multi-leaf collimator modules for medical linear accelerators
- Parts of radiation generators
- Flat panel detectors for digital radiography systems
- Special detectors for X-ray tomography scanners
- Scintillators, photoelectric conversion modules, and collimators for X-ray tomography scanners
- High-voltage generators for X-ray tomography scanners
In Vitro Diagnostic Reagents
- Culture media for the growth or maintenance of microorganisms, plant, human, or animal cells
- Diagnostic or laboratory reagents on a backing for malaria
- Prepared diagnostic kits for Hepatitis A virus, Hepatitis B virus, Hepatitis C virus, Human Immunodeficiency Virus, and Treponema pallidum
- Other prepared diagnostic or laboratory reagents (not elsewhere specified)
To deepen economic and trade cooperation and promote regional integration, China has continued applying agreed tariff rates to certain imported goods originating from its 34 trading partners in 2026, in accordance with 24 free trade agreements and preferential trade arrangements signed with the above-mentioned trading partners.
In 2026, China also has maintained zero-tariff treatment on 100 percent of tariff lines to the 43 least developed countries having established diplomatic relations with China.